Delivery Order SPE2DB22D1103-SPE2DB25FH0B1
- Not listed
- The Defense Logistics Agency awarded a $13,451.77 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed price contract has a completion date of July 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $41,840.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This is a non-set-aside competitive award with an ultimate completion date of September 3, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $31,772.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 17, 2025. This competitive award, issued on July 16, 2025, carries a firm fixed price and involves no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution and pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, valued at $13,414.74. The contract utilizes a firm fixed price structure with no set-aside designation, indicating open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with a contract value of $1,540.59. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was issued without a set-aside designation, indicating the contract was...
- The Defense Logistics Agency awarded a $14,981.54 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and is performed from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $15,039.84 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract is a firm fixed price, non-set-aside delivery order with a completion deadline of September 4, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a contract ceiling value of $5,639.94 and an ultimate completion date of July 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) vials with a ceiling value of $1,483.29. This is a firm fixed-price, non-competitive set-aside delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $9,238.16 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of September 19, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH0B1Delivery Order
The Defense Logistics Agency awarded a $11,665.96 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive DLA contract vehicle. This delivery order for Ozempic, a diabetes medication, represents part of the contractor's extensive portfolio of brand-name and generic pharmaceutical products delivered through competitive firm fixed-price orders. The contract award demonstrates AmerisourceBergen's continued capability to meet federal medical supply requirements, with historical contract values ranging from under $100 to over $45,000, supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 8/14/25 |